Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

In the context of an overdose crisis linked to fentanyl, we used drug checking data to examine variability within the illicit opioid supply.

Original research | 2022
Overdose, Evidence base, Drug checking, Illegal drugs
Report | 2022
Safer supply, Evidence base, Policy/Regulatory, Outcomes
Page Web | 2022
l'approvisionnement plus sécuritaire, la politique / le cadre de réglementation, la base de donnés probantes, les résultats

This is a summary of an independent assessment report prepared by Dale McMurchy Consulting based on information gathered through surveys and interviews with safer supply program leads, staff and pa

Webpage | 2022
Safer supply, Policy/Regulatory, Evidence base, Outcomes

This research assessed the impact of COVID-19 on staff working at harm reduction and alcohol and other drug (AOD) services in Australia in the first 9 months of the pandemic.

Original research | 2022
Wrap-around services, Harm reduction

Given the continued expansion of community pharmacy in the continuum of care, it is imperative to characterize alcohol use among pharmacy patients dispensed opioids in order to establish a foundati

Original research | 2022
About pharmacists
Webpage | 2022
Policy/Regulatory, Safer supply
Guidelines | 2018
SCS/OPS, Clinical guidance, Harm reduction, Social services, Illegal drugs

This Evidence Brief asks: What is the evidence of effectiveness of supervised injectable opioid agonist treatment with diacetylmorphine (DAM) or hydromorphone (HDM) on treatment retention (i.e., in

Report | 2017
Evidence base, Safer supply
Report | 2019
Policy/Regulatory, Advocacy, Illegal drugs, Crime
Formulaire de sélection/d’évaluation | 2022
À propos des personnes qui utilisent des drogues, À propos des prescripteurs, les guides de pratique clinique, le sevrage, l'équité

The Clinical Opiate Withdrawal Scale (COWS) is a validated, clinician-administered instrument initially developed and validated for English-speaking populations.

Original research | 2022
Clinical guidance, Equity, Withdrawal, About prescribers

Social distancing measures and service restrictions posed significant challenges to the health and wellbeing of PWUD.

Original research | 2022
Harm reduction, About PWUD, Policy/Regulatory

Black clients in substance use disorder (SUD) treatment are associated with the lowest successful completion and substance use reductions.

Original research | 2022
Barriers and enablers, About PWUD, Equity, Outcomes, Wrap-around services
Rapport | 2021
la surdose, la mortalité, À propos des personnes qui utilisent des drogues
Report | 2021
Overdose, Mortality, About PWUD
Original research | 2022
Safer supply, Policy/Regulatory, Stimulants, Illegal drugs

To estimate effects of brief substance use interventions delivered in general medical settings.

Lit review | 2022
About prescribers, Illegal drugs, Hospitals, Outcomes

To characterize comparative risks and benefits of methadone versus buprenorphine/naloxone in a contemporary cohort where the unregulated drug supply is dominated by fentanyl.

Original research | 2022
Overdose, Substitution, About PWUD, Outcomes

Refine Your Search

Keywords
Format
Region